NYMX
Nymox Pharmaceutical Corp
NYMX
NYMX
Delisted
NYMX was delisted on the 6th of July, 2023.
58 hedge funds and large institutions have $14.2M invested in Nymox Pharmaceutical Corp in 2020 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 21 increasing their positions, 14 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
68% less call options, than puts
Call options by funds: $27K | Put options by funds: $84K
Holders
58
Holding in Top 10
–
Calls
$27K
Puts
$84K
Top Buyers
| 1 | +$241K | |
| 2 | +$192K | |
| 3 | +$70K | |
| 4 |
Morgan Stanley
New York
|
+$61K |
| 5 |
Invesco
Atlanta,
Georgia
|
+$60.2K |
Top Sellers
| 1 | -$250K | |
| 2 | -$150K | |
| 3 | -$106K | |
| 4 |
Russell Investments Group
London,
United Kingdom
|
-$104K |
| 5 |
HAG
HighPoint Advisor Group
Downers Grove,
Illinois
|
-$73K |